Compound information
- Natural Products
- ZC742633
- Molecular Formula
- C21H30N4O6S
- Molecular Weight
- 466.18860568 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[1-(4-acetamidophenyl)sulfonylpiperidine-4-carbonyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C21H30N4O6S/c1-3-31-21(28)24-14-12-23(13-15-24)20(27)17-8-10-25(11-9-17)32(29,30)19-6-4-18(5-7-19)22-16(2)26/h4-7,17H,3,8-15H2,1-2H3,(H,22,26)
- InChI Key
- WNHWWLRRFWVNPP-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NC(C)=O)cc3)CC2)CC1
- Source
- ZINC000013607354
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 32 | Ring Count | 3 |
Heteroatom Count | 11 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 116.33 Å2 | LogP | 0.765 |
LogS | -3.419 | LogD | 1.231 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.022 | Pgp substrate | 0.996 |
HIA | 0.971 | F20 % | 0.981 |
F30 % | 0.187 | Caco-2 | -4.913 |
MDCK | -5.082 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.01 | PPB | 55.565 |
VD | 0.966 | Fu | 0.574 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.467 |
CYP2A6 substrate | 0.357 | CYP2B6 substrate | 0.573 |
CYP2C19 inhibitor | 0.227 | CYP2C19 substrate | 0.739 |
CYP2C8 substrate | 0.631 | CYP2C9 inhibitor | 0.214 |
CYP2C9 substrate | 0.992 | CYP2D6 inhibitor | 0.031 |
CYP2D6 substrate | 0.411 | CYP2E1 substrate | 0.245 |
CYP3A4 inhibitor | 0.016 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.497 | CL | 2.193 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.035 | Hepatotoxicity | 0.477 |
Mutagenicity | 0.511 | Rat Oral Acute Toxicity | 0.189 |
FDAMDD | 0.244 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.089 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.008 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.161 | IGC50 | 2.283 |
LC50FM | -16.593 | LC50DM | -6.108 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.462 | NR-AR-LBD | 0.341 |
NR-AhR | 0.071 | NR-Aromatase | 0.016 |
NR-ER | 0.294 | NR-ER-LBD | 0.384 |
NR-PPAR-gamma | 0.102 | SR-ARE | 0.451 |
SR-ATAD5 | 0.301 | SR-HSE | 0.06 |
SR-MMP | 0.011 | SR-p53 | 0.085 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.